Scientists unravel how TET2 gene deficiency fuels development of acute myeloid leukaemia
Scientists at City of Hope, one of the largest cancer research and treatment organisations in the…
Scientists at City of Hope, one of the largest cancer research and treatment organisations in the…
On July 20, 2023, the Food and Drug Administration approved quizartinib with standard cytarabine and…
Researchers have developed a new method to distinguish between cancerous and healthy stem cells and…
Tisch Cancer Center scientists developed unique models of the deadliest blood cancer, acute myeloid leukaemia…
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable…
A new targeted drug has not only sparked remissions in patients with a common form…
Despite recent therapeutic advances, acute myeloid leukaemia (AML) continues to be associated with poor outcomes…
Professor John Pimanda receives the new Translational Program Grant for his team’s work with acute myeloid…
Severe inflammation weakens the body’s ability to kill cancerous blood cells in people with acute…
Researchers observed encouraging response rates in older or high-risk patients with newly diagnosed acute myeloid…